搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The Edge Singapore
4 小时
Panellists at MooSummit 2024 identify interesting investing themes
Older Singapore investors can opt for ETFs in Singapore dollars (SGD) listed on the Singapore Exchange S68 The MooSummit took ...
6 小时
Ozempic could help with opioid and alcohol abuse, new research shows
Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.
来自MSN
8 小时
Lilly Loses Around $14B This Week: How to Play LLY Stock
The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.
11 小时
Ozempic and other weight loss drugs could help treat alcohol and drug addiction, study says
The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.
11 小时
2 High-Flying Growth Stocks With Massive Upside Potential
The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...
15 小时
This is Huge News For Eli Lilly Investors
As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...
ConsumerAffairs
1 天
Compounding pharmacies can keep making Mounjaro and Zepbound copies
The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...
Health.com
1 天
What the End of a Tirzepatide Shortage Would Mean for Access to Compounded Weight Loss Drugs
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...
1 天
3 Reasons Eli Lilly Stock Isn't Going to Run out of Steam Anytime Soon
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
HealthLeaders Media
1 天
Healthy Returns: Covering weight loss drugs could cost Medicare $35B through 2034
Those include GLP-1s for obesity such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound, which both carry hefty price tags of roughly $1,000 per month before insurance and other rebates.
The Times of Northwest Indiana
1 天
Get Healthy: Drugs can jump-start weight loss, giving healthy eating, exercise habits time ...
“ (Weight loss medications) can help, for sure, but exercise and getting enough protein to make sure you aren’t losing muscle ...
1 天
on MSN
Eli Lilly's tirzepatide is off the FDA's shortage list: What it means for patients
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈